1. Home
  2. Labeler Index
  3. Viiv Healthcare Company
  4. 49702-264
  5. NDC Package Code: 49702-264-23 Apretude

NDC Package 49702-264-23 Apretude

Cabotegravir Kit - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
49702-264-23
Package Description:
1 KIT in 1 CARTON * 3 mL in 1 VIAL (49702-238-03)
Product Code:
49702-264
Proprietary Name:
Apretude
Non-Proprietary Name:
Cabotegravir
Usage Information:
APRETUDE is indicated in at-risk adults and adolescents weighing at least 35 kg for pre‑exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection. Individuals must have a negative HIV-1 test prior to initiating APRETUDE (with or without an oral lead-in with oral cabotegravir) for HIV-1 PrEP [see Dosage and Administration (2.2, 2.4), Contraindications (4), Warnings and Precautions (5.1)].
11-Digit NDC Billing Format:
49702026423
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 2588077 - cabotegravir 600 MG in 3 ML Extended Release Injection
  • RxCUI: 2588077 - 3 ML cabotegravir 200 MG/ML Injection
  • RxCUI: 2588077 - cabotegravir 600 MG per 3 ML Injection
  • RxCUI: 2588080 - Apretude 600 MG in 3 ML Extended Release Injection
  • RxCUI: 2588080 - 3 ML cabotegravir 200 MG/ML Injection [Apretude]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Viiv Healthcare Company
    Dosage Form:
    Kit - A packaged collection of related material.
    Sample Package:
    No
    FDA Application Number:
    NDA215499
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    12-20-2021
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 49702-264-23?

    The NDC Packaged Code 49702-264-23 is assigned to a package of 1 kit in 1 carton * 3 ml in 1 vial (49702-238-03) of Apretude, a human prescription drug labeled by Viiv Healthcare Company. The product's dosage form is kit and is administered via form.

    Is NDC 49702-264 included in the NDC Directory?

    Yes, Apretude with product code 49702-264 is active and included in the NDC Directory. The product was first marketed by Viiv Healthcare Company on December 20, 2021 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 49702-264-23?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 49702-264-23?

    The 11-digit format is 49702026423. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-249702-264-235-4-249702-0264-23